RecruitingPhase 3NCT06776783

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Studying Infant acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Aerogen Pharma Limited
Intervention
APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system)(combination_product)
Enrollment
520 target
Eligibility
All sexes
Timeline
20252029

Study locations (9)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06776783 on ClinicalTrials.gov

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Infant acute respiratory distress syndrome

← Back to all trials